CoV Biotechnology

acquired

Stage

About

CoV Biotechnology develops booster vaccines and therapeutics effective against SARS-2 beta coronavirus variants, including a pan-sarbecovirus vaccine to protect against future variants and zoonotic crossovers.

Explore CoV Biotechnology's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.